Evidence map›Paper›PMID 31632973›Full record

ReviewFrontiers in medicine2019

Translational AI and Deep Learning in Diagnostic Pathology.

Ahmed Serag, Adrian Ion-Margineanu, Hammad Qureshi, Ryan McMillan, Marie-Judith Saint Martin, Jim Diamond, Paul O'Reilly, Peter Hamilton

Abstract readReview
In one paragraph

Review in Frontiers in medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Pathology Foundation Models.JMA journal · 2025
    Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ahmed SeragLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Adrian Ion-MargineanuLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Hammad QureshiLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Ryan McMillanLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Marie-Judith Saint MartinLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Jim DiamondLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Paul O'ReillyLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.
Peter HamiltonLife Sciences R&D Hub, Digital and Computational Pathology, Philips, Belfast, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been an exponential growth in the application of AI in health and in pathology. This is resulting in the innovation of deep learning technologies that are specifically aimed at cellular imaging and practical applications that could transform diagnostic pathology. This paper reviews the different approaches to deep learning in pathology, the public grand challenges that have driven this innovation and a range of emerging applications in pathology. The translation of AI into clinical practice will require applications to be embedded seamlessly within digital pathology workflows, driving an integrated approach to diagnostics and providing pathologists with new tools that accelerate workflow and improve diagnostic consistency and reduce errors. The clearance of digital pathology for primary diagnosis in the US by some manufacturers provides the platform on which to deliver practical AI. AI and computational pathology will continue to mature as researchers, clinicians, industry, regulatory organizations and patient advocacy groups work together to innovate and deliver new technologies to health care providers: technologies which are better, faster, cheaper, more precise, and safe.

Indexed as

artificial intelligencecomputational pathologydeep learningdigital pathologyimage analysismachine learningneural networkpathology

Identifiers

PMID31632973
PMCPMC6779702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.